Objective
This annual conference will update patent litigators and attorneys on the ongoing European and EU initiatives in the field of patent law. The focus will be on emerging technologies used as medical therapies or treatment methods on the human being, including genome engineering, biomedical applications of human stem cells and nucleic acid-related inventions.
Key topics
- The EU Biotech Directive 98/44: still fit for purpose?
- Patenting of diagnostic methods in Europe and the USA
- Patenting of human embryonic stem cells
- Patenting gene and gene-editing tool
- EPO current practice on patenting life science inventions
- The EU/EPC saga on the definition of “essentially biological processes”
- Legal tools to facilitate access to patented biotechnologies
- Life science between patent law and Artificial Intelligence
Who should attend?
Litigators specialised in patent law, in-house counsel and European patent attorneys.
Fees in €:
|
Standard
|
EU and ERA patrons
|
Young lawyers and other groups
|
Discount Voucher Code (see details below)
|
Registration
|
|
|
|
|
|
More details about the fees and discounts
Early registration discount
10 % before 07.10.2019
Discounts available
25 % - For young lawyers up to 30 years of age (important: the participant must provide a copy or details of his or her passport or identity card on registration); Full-time staff of universities or comparable academic institutions; Staff of charitable organisations or comparable institutions
25 % - Discount Voucher Code
If you have a discount voucher code, please click on the option above and enter the code in the Voucher Field when you register.
40% - For Staff of European Union institutions and agencies; Staff of ERA’s patrons: all EU Member States (Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, United Kingdom), the German states, Scotland and the City of Trier.